INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 109 filers reported holding INTERSECT ENT INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $9,079,000 | -62.7% | 531,229 | -54.5% | 0.28% | -59.2% |
Q1 2021 | $24,356,000 | +11.3% | 1,166,460 | +22.1% | 0.69% | -12.7% |
Q4 2020 | $21,886,000 | +55.9% | 955,723 | +11.0% | 0.80% | +9.8% |
Q3 2020 | $14,040,000 | -7.9% | 860,816 | -23.6% | 0.72% | -50.6% |
Q2 2020 | $15,251,000 | +88.8% | 1,126,374 | +65.2% | 1.47% | +53.0% |
Q1 2020 | $8,080,000 | -76.6% | 681,865 | -50.7% | 0.96% | -68.4% |
Q4 2019 | $34,471,000 | +40.2% | 1,384,360 | -4.2% | 3.03% | -27.8% |
Q3 2019 | $24,580,000 | +111.4% | 1,445,000 | +182.9% | 4.20% | +137.9% |
Q2 2019 | $11,626,000 | +22.2% | 510,826 | +72.7% | 1.76% | +30.5% |
Q1 2019 | $9,511,000 | +77.3% | 295,826 | +55.4% | 1.35% | +26.2% |
Q4 2018 | $5,364,000 | -34.2% | 190,335 | -32.9% | 1.07% | -37.6% |
Q3 2018 | $8,151,000 | +52.7% | 283,527 | +99.0% | 1.72% | -19.8% |
Q2 2018 | $5,337,000 | +23.5% | 142,500 | +29.5% | 2.14% | -16.2% |
Q1 2018 | $4,323,000 | +33.4% | 110,000 | +10.0% | 2.55% | +88.3% |
Q4 2017 | $3,240,000 | -48.0% | 100,000 | -50.0% | 1.36% | -25.6% |
Q3 2017 | $6,230,000 | +10.3% | 200,000 | -1.0% | 1.82% | -18.7% |
Q2 2017 | $5,646,000 | -15.1% | 201,998 | -47.9% | 2.24% | +13.9% |
Q1 2017 | $6,653,000 | +931.5% | 387,922 | +12830.7% | 1.97% | +733.9% |
Q4 2016 | $645,000 | -85.2% | 3,000 | -98.9% | 0.24% | -82.2% |
Q3 2016 | $4,356,000 | +6.9% | 275,000 | -12.7% | 1.32% | -23.6% |
Q2 2016 | $4,073,000 | +229.0% | 315,000 | +472.7% | 1.73% | +231.2% |
Q4 2015 | $1,238,000 | – | 55,000 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|